drug · small molecule
SUSTOL
updated 6mo agoby $HRTX HERON THERAPEUTICS, INC. /DE/🔗 ChEMBL
community read0 votes
🐶 often sniffed alongside
top 2Small molecule drug with a maximum clinical stage of Approval (across all indications), with 5 approved and 6 investigational indications.
targets
5-hydroxytryptamine receptor 3A
all catalysts(0)
nothing on the calendar yet
Trials studying SUSTOL
- phase4Safety Study of Repeat Doses of SUSTOL in Adults
- phase1Staccato® Granisetron Single Dose PK
- phase4Oral Akynzeo® vs Standard of Care in Preventing CINV in High-risk MEC Patients (MyRisk)
- phase1Granisetron 1 mg Tablets, Non-fasting
- phase1Granisetron 1 mg Tablets Under Fasting Conditions
- phase1Safety and Pharmacokinetics of Sancuso and IV Granisetron in Patients Aged 2 to 5 Years
- phase1Pharmacokinetics and Safety of Sancuso and IV Granisetron in Pediatrics Aged 6 to 12 Years
- phase1An Investigation on the Effect of Age and BMI on the Pharmacokinetics of Transdermal Granisetron
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 1h ago
Found something off?
comments(0)
5-min edit window · permanent after that